Ortoma AB Series B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more
Ortoma AB Series B (ORT-B) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.066x
Based on the latest financial reports, Ortoma AB Series B (ORT-B) has a cash flow conversion efficiency ratio of -0.066x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-10.96 Million) by net assets (Skr164.90 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ortoma AB Series B - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Ortoma AB Series B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ortoma AB Series B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ortoma AB Series B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
INOVIQ LTD.
F:EGQ0
|
N/A |
|
Foremost Lithium Resource & Technology Ltd. Common stock
NASDAQ:FMST
|
-0.050x |
|
Aetherium Acquisition Corp
NASDAQ:GMFI
|
N/A |
|
Full Circle Lithium Corp.
PINK:FCLIF
|
-0.109x |
|
INVENTUS MNG CORP.
F:3GIA
|
N/A |
|
TOP Engineering Co. Ltd
KQ:065130
|
0.098x |
|
SRP Groupe SA
PA:SRP
|
0.135x |
|
Daemyung Sonoseason Co.Ltd
KQ:007720
|
-0.048x |
Annual Cash Flow Conversion Efficiency for Ortoma AB Series B (2021–2024)
The table below shows the annual cash flow conversion efficiency of Ortoma AB Series B from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr161.91 Million | Skr-22.01 Million | -0.136x | -276.65% |
| 2023-12-31 | Skr173.54 Million | Skr13.35 Million | 0.077x | +206.13% |
| 2022-12-31 | Skr114.29 Million | Skr-8.29 Million | -0.073x | +37.94% |
| 2021-12-31 | Skr130.04 Million | Skr-15.19 Million | -0.117x | -- |